New Key Statistics Module, Z-Score and F-Score
NAS:SYRS Key Ratios
Market Cap $ M | 44.50 |
Enterprise Value $ M | 26.20 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 11.29 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 4.00 |
EPS (TTM) $ | -4.34 |
Beneish M-Score | -4.39 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 23.10 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.21 |
EV-to-EBITDA | -0.21 |
PEG | -- |
Shares Outstanding M | 26.81 |
Net Margin (%) | -3,171.70 |
Operating Margin % | -2,835.68 |
Pre-tax Margin (%) | -3,171.70 |
Quick Ratio | 3.46 |
Current Ratio | 3.46 |
ROA % (ttm) | -89.09 |
ROE % (ttm) | -487.60 |
ROIC % (ttm) | -324.23 |
Dividend Yield % | -- |
Altman Z-Score | -12.79 |
SYRS Number of Guru Trades
SYRS Volume of Guru Trades
Gurus Latest Trades with NAS:SYRS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SYRS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Syros Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:SYRS
Total 0- 1